BusinessUpdated 23 min ago
Cipla’s US manufacturing facility gets ‘No Action Indicated’ status from FDA

The US regulator issued the classification on November 17, following a four-day inspection of the manufacturing facility in New York
Continue reading on BusinessLine
Read full story Hello Headlines links you to the original publisher for the full story.

